Mark A. Liker

Mark A. Liker, MD, is a Clinical Assistant Professor (Part-Time) in the Department of Neurological Surgery at the University of Southern California (USC). He is affiliated with the USC Clinical and Translational Science Institute (CTSI) and specializes in innovative neurosurgical techniques, particularly in the application of deep brain stimulation (DBS) for pediatric movement and neuropsychiatric disorders. His work bridges clinical practice with neurotechnology, emphasizing personalized surgical approaches and interdisciplinary collaboration.

Research Interests: Dr. Liker’s primary focus is on advancing DBS therapies for children and young adults with dystonia and related neurological conditions. He also explores electropalatography (EPG) advancements in speech therapy and rehabilitation, alongside broader applications of neurotechnology in medical innovation. His interests include genetic mutations impacting neurological outcomes (e.g., TUBB4A, MEPAN syndrome), cognitive effects of DBS in Parkinson’s disease, and optimizing surgical corridors for complex pediatric neurosurgical procedures.

Publications Trends: His recent work highlights DBS personalization for pediatric cases, EPG-driven speech analysis, and the integration of neurotechnology into clinical practice. He frequently publishes in journals like Neurosurg Focus, Brain Stimul, and Phonetica, reflecting his dual expertise in neurological surgery and speech rehabilitation.

• Scientific Awards: Honored Guest Presentation at Clin Neurosurg 2002 for contributions to neurorestoration and molecular/cellular neurosurgery.

Advising & Grants: While no formal advisees or grants are listed here, Dr. Liker’s publications suggest active involvement in clinical research and collaborative projects, especially at Children’s Hospital Los Angeles. His work often involves pilot studies and case reports, indicating a hands-on role in advancing treatments.

Labs/Teams: Affiliated with the Department of Neurological Surgery at USC and the Children’s Hospital Los Angeles, where he contributed to DBS case studies. He collaborates with speech therapy researchers (e.g., via EPG symposium reports) and neurotechnology developers.